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We evaluated the effects of chronic allergic airway inflammation and of treadmill training (12 weeks) of low and moderate
intensity on muscle fiber cross-sectional area and mRNA levels of atrogin-1 and MuRF1 in the mouse tibialis anterior muscle.
Six 4-month-old male BALB/c mice (28.5 ± 0.8 g) per group were examined: 1) control, non-sensitized and non-trained (C); 2)
ovalbumin sensitized (OA, 20 μg per mouse); 3) non-sensitized and trained at 50% maximum speed – low intensity (PT50%); 4)
non-sensitized and trained at 75% maximum speed – moderate intensity (PT75%); 5) OA-sensitized and trained at 50%
(OA+PT50%), 6) OA-sensitized and trained at 75% (OA+PT75%). There was no difference in muscle fiber cross-sectional area
among groups and no difference in atrogin-1 and MuRF1 expression between C and OA groups. All exercised groups showed
significantly decreased expression of atrogin-1 compared to C (1.01 ± 0.2-fold): PT50% = 0.71 ± 0.12-fold; OA+PT50% = 0.74
± 0.03-fold; PT75% = 0.71 ± 0.09-fold; OA+PT75% = 0.74 ± 0.09-fold. Similarly significant results were obtained regarding
MuRF1 gene expression compared to C (1.01 ± 0.23-fold): PT50% = 0.53 ± 0.20-fold; OA+PT50% = 0.55 ± 0.11-fold; PT75% =
0.35 ± 0.15-fold; OA+PT75% = 0.37 ± 0.08-fold. A short period of OA did not induce skeletal muscle atrophy in the mouse tibialis
anterior muscle and aerobic training at low and moderate intensity negatively regulates the atrophy pathway in skeletal muscle
of healthy mice or mice with allergic lung inflammation.
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Introduction
Asthma is a chronic airway inflammatory disease re-
lated to a progressive decrease in lung function and also of
the physical capacity to exercise (1). Many clinical and
experimental studies have suggested that decreased lung
function can be attributed directly to airway inflammation
and remodeling (2,3). In addition, decreased physical ca-
pacity is normally considered to be secondary to decreased
lung function (4), and is strongly related to the psychoso-
cial effects of asthma (5) and to peripheral skeletal muscle
disuse (6). These secondary effects have been demon-
strated in both asthmatic children and adults (7).
Two recent studies have shown an increase in the
mRNA expression of muscle-specific genes related to
atrophy in chronic obstructive pulmonary disease (COPD).
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Doucet and colleagues (8) reported an increase in atrogin-
1 and MuRF1 (232 and 517%, respectively) mRNA in the
quadriceps muscle of patients with COPD. Furthermore,
Ottenheijm et al. (9) also showed an increase in atrogin-1
gene expression in the diaphragm muscle of patients with
mild to moderate COPD. Atrogin-1 and MuRF1 mRNA
levels are reliable molecular markers for muscle atrophy
by being increased substantially in peripheral skeletal
muscle in various muscle-wasting conditions, such as
denervation, immobilization, cancer, sepsis, and aging
(10-12). However, the molecular mechanism involved in the
skeletal muscle weakness in asthmatic subjects is unknown.
Aerobic physical training has been recommended as
an effective adjuvant treatment in the management of
asthmatic patients (13,14). Aerobic physical training trig-
gers several beneficial effects in asthmatic patients such
as improvement in physical fitness and ventilatory capac-
ity and a decrease in asthma-related symptoms, exercise-
induced bronchospasm, and daily use of inhaled steroids
(15-18). Other investigators have demonstrated that asth-
matic patients submitted to an aerobic physical training
program also present improved respiratory and peripheral
muscle strength and function (19,20). However, the mech-
anisms underlying these effects are unknown.
We recently demonstrated that animals previously sub-
mitted to chronic airway allergic inflammation followed by
aerobic exercise training presented a decrease in airway
inflammation and remodeling in a murine model of asthma
(21). Nevertheless, relatively little is known about the ef-
fects of aerobic training before the development of the
allergic response in peripheral skeletal muscles of asth-
matic animals. This aspect should be important because
skeletal muscle wasting frequently afflicts asthmatic pa-
tients (5,22,23) and it would be important to determine if
aerobic training before the induction of asthma could pro-
vide some kind of muscle protection.
On the basis of these considerations, we hypothesized
that chronic allergic lung inflammation should reduce the
cross-sectional area (CSA) of the muscle fibers and in-
crease the expression of atrogin-1 and MuRF1 in the
tibialis anterior (TA) muscle. A corollary was that aerobic
physical training applied before the induction of chronic
allergic lung inflammation could reduce these effects. Since
different intensities of aerobic training may induce different
adaptations in the asthmatic inflammatory response (21,24,
25), we analyzed the effect of two aerobic treadmill training
intensities in the present study.
Therefore, the purpose of the present study was to
evaluate the effects of aerobic treadmill training of low and
moderate intensity before and during chronic allergic lung
inflammation on the CSA of the muscle fibers and on
mRNA levels of atrogin-1 and MuRF1 in the mouse TA
muscle. In view of the similarities among mammalian
muscles, the results of this study could provide new infor-
mation for the understanding and use of treadmill training
regarding peripheral muscles in asthma.
Material and Methods
The study was approved by the review board for hu-
man and animal studies of the School of Medicine, Univer-
sity of São Paulo, and was conducted in compliance with
the national guidelines of the Guide for Care and Use of
Laboratory Animals (26).
Animals and experimental design
Thirty 4-month-old male BALB/c mice (28.5 ± 0.8 g)
were randomly divided into 6 groups of 5 animals each: 1)
non-sensitized and non-trained (control group); 2) ovalbu-
min-sensitized and non-trained (OA group); 3) non-sensi-
tized and treadmill trained at 50% maximum speed – low
intensity (PT50%); 4) non-sensitized and treadmill trained
at 75% maximum speed – moderate intensity (PT75%); 5)
OA-sensitized and treadmill trained at 50% maximum speed
(OA+PT50%), and 6) OA-sensitized and treadmill trained
at 75% maximum speed (OA+PT75%).
Aerobic exercise treadmill test and aerobic conditioning
Animals were initially adapted to the treadmill for 3
days (15 min, 0.2 km/h). Next, a maximal exercise capacity
test was performed with a 5-min warm-up (0.2 km/h) fol-
lowed by an increase in treadmill speed (every 2.5 min)
until animal exhaustion, i.e., after 10 mechanical stimuli
(21). Maximal aerobic capacity (100%) was established as
the maximal speed reached by each animal. Mice were
exercise trained at low or moderate intensity (50 or 75% of
maximal speed reached in the test, respectively) for 60 min
a day, 5 days a week for 12 weeks (8 weeks before
sensitization + 4 weeks after OA or saline exposure) (21).
The improvement in exercise capacity was confirmed by
repeating the maximal exercise test after 12 weeks of
physical training (72 h before sacrifice). Non-trained ani-
mals were submitted to a protocol that included 5 min of
exercise on the treadmill at 0.5 km/h, 3 times a week, so
that the animals would not present any effect when per-
forming the second and third maximal exercise tests.
Antigen sensitization
The antigen sensitization period was started during the
9th week of physical training and lasted for 4 weeks. The
mice were sensitized by intraperitoneal (ip) injection of OA
(20 μg per mouse) adsorbed with aluminum hydroxide on
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days 0 and 14 or with saline (0.9% NaCl), the diluent of OA.
During the last week, the mice were challenged with 1%
aerosolized OA or with saline 4 times, every other day, for
30 min per session. Challenging with aerosolized OA (or
saline) was performed in an acrylic box (30 x 15 x 20 cm)
coupled to an ultrasonic nebulizer.
Animal anesthesia and euthanasia
Seventy-two hours after the last training section and
antigen sensitization protocols, animals were anesthe-
tized by ip injection of xylazine (12 mg/kg) and ketamine
(95 mg/kg) for muscle dissection and euthanized with an
overdose of the anesthetic.
Muscle evaluation
The TA muscle was chosen because almost all fibers
cross the middle belly of the muscle and are distributed
from tendon to tendon. In addition, it is a large muscle, and
thus allows the evaluation of muscle fiber CSA and gene
expression in the same muscle. The mice were weighed
and both the right and left TA muscles carefully removed
and weighed. The left TA was used for morphological
evaluation and was immediately frozen in isopentane, pre-
cooled in liquid nitrogen, and stored in a freezer at -80°C
(Forma Scientific, USA). Serial cross-sections (10 μm)
were then obtained from the middle belly of the frozen left
TA muscles using a cryostat microtome (Microm HE 505,
Germany) and stained with 1% toluidine blue/1% borax.
The right TA was used for mRNA analysis and was frozen
in liquid nitrogen and also stored at -80°C, as previously
described (27,28).
Muscle fiber cross-sectional area
One histological cross-section from the middle belly of
each left TA muscle was used to measure the muscle fiber
CSA in the central region of the histological section. A light
microscope (Axiolab, Carl Zeiss, Germany) equipped with
a digital camera (Sony DSC S75, Japan) was used. The
CSA of 200 randomly chosen fibers per mouse was meas-
ured using the Axiovision 3.0.6 SP4 software (Zeiss) (27,28).
RNA isolation and analysis
RNA was isolated from each frozen right TA muscle
using 1 mL Trizol reagent (Invitrogen, USA) in accordance
with manufacturer instructions. The extracted RNA was
dissolved in Tris-HCl and ethylenediaminetetraacetic acid,
pH 7.6, and quantified by spectrophotometry. Purity was
assessed by determining the ratio of the absorbance at
260 and 280 nm. All samples had 260/280 nm ratios above
2.0. RNA integrity was confirmed by inspection of ethidium
bromide-stained 18S and 28S ribosomal RNA under ultra-
violet light (Invitrogen).
Reverse transcription
Total RNA was reverse transcribed to synthesize cDNA
in two steps. First, 1 μL oligo (dT) primer (Invitrogen) and
9.5 μL water were added to 1 μg total RNA, heated to 70°C
for 10 min and quickly cooled on ice. Second, each sample
was incubated in 4 μL 5X reverse transcription buffer, 1 μL
of a dNTP (Promega, USA) mixture containing 0.2 mM
each of dATP, dCTP, dGTP, and dTTP, 2 μL 0.1 M dithio-
threitol and 0.5 μL M-MLV RT enzyme (Promega) in a total
volume of 20 μL at 42°C for 60 min. To minimize variation
in the reverse transcription reaction, all RNA samples were
reverse transcribed simultaneously.
Oligonucleotide primers
Oligonucleotide primers were designed for atrogin-1
(GenBank, AF441120), MuRF1 (GenBank, AY059627) and
GAPDH (AF106860) using the Primer Express Software
2.0 (Applied Biosystems, USA). The sequences used were
from rat atrogin-1 (forward: TACTAAGGAGCGCCATGGA
TACT; reverse: GTTGAATCTTCTGGAATCCAGGAT),
from rat MuRF1 (forward: TGACCAAGGAAAACAGCCAC
CAG; reverse: TCACTCCTTCTTCTCGTCCAGGATGG)
and from rat GAPDH (forward: CCACCAACTGCTTAG
CCC; reverse: GCCAAATTCGTTGTCATACC) genes.
Analysis by the real-time polymerase chain reaction
mRNA from the experimental and control muscles was
amplified with a Rotor Gene 3000 cycler (Cobert’s, Sydney,
Australia). The amplification mixtures contained 1 μL cDNA
sample, 25 μL of the fluorescent dye SYBR green Master
mix (Applied Biosystems) and 180 nM of each primer in a
final volume of 50 μL.
Thermal cycling conditions for atrogin-1, MuRF1 and
GAPDH included 10 min at 95°C and then 40 cycles each
of 15 s at 94°C, 30 s at 56°C for atrogin-1, at 64°C for
MuRF1, and at 56°C for GAPDH, respectively, and 1 min at
72°C, followed by 10 min at 72°C. For each gene, all
samples were amplified simultaneously in duplicate in one
assay run. Data were analyzed using the comparative
cycle threshold method. Target gene expression was nor-
malized for the GAPDH gene as reported by others (29).
Statistical analysis
Levine’s test was applied first to evaluate the homoge-
neity of the results. Two-way ANOVA (factors: exercise
and sensitization with OA) was used to identify possible
differences amongst groups. When differences were ob-
served, the Tukey test was applied. For all tests, the level
of significance was set at 5% (P ≤ 0.05).
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Results
Body and tibialis anterior muscle weight and cross-
sectional area
All groups presented an increase in body weight (P <
0.05) but no statistical difference was found among them
(Table 1). Although the weight of the TA muscle was
slightly lower in the OA+PT50% and OA+PT75% groups,
no statistical differences in muscle fiber CSA were de-
tected among the groups studied.
Aerobic exercise capacity
Figure 1 shows the average improvement in time of
maximal exercise between the final and initial tests in all
groups. Animals did not present any difference in the first
exercise test (P > 0.05) and the average exercise time was
39.40 ± 0.45 min (data not shown). After 8 weeks, the non-
trained groups (control and OA) did not present any im-
provement in exercise capacity. On the other hand, the
trained groups presented statistically significant improve-
ment in maximal exercise capacity in the final test (P < 0.05).
Atrogin-1 and MuRF1 gene expression
Atrogin-1 gene expression was not altered in the OA
group compared to control (Figure 2A). However, aerobic
training significantly decreased atrogin-1 gene expression
in the TA muscles of all trained groups compared to control
(1.01 ± 0.2-fold): PT50% = 0.71 ± 0.12-fold; OA+PT50% =
0.74 ± 0.03-fold; PT75% = 0.71 ± 0.09-fold; OA+PT75% =
0.74 ± 0.09-fold (Figure 2A).
Similar results were obtained for MuRF1 gene expres-
sion, which was unchanged in the OA group compared to
control (P = 0.89; Figure 2B). In addition, decreased MuRF1
gene expression was also found in TA muscles after
aerobic training compared to control (1.01 ± 0.23-fold):
PT50% = 0.53 ± 0.20-fold; OA+PT50% = 0.55 ± 0.11-fold;
PT75% = 0.35 ± 0.15-fold; OA+PT75% = 0.37 ± 0.08-fold
(Figure 2B).
Table 1. Effect of exercise training on body weight, tibialis anterior muscle weight and cross-sectional area.
Control OA PT50% PT75% OA+PT50% OA+PT75%
Initial body weight (g) 26.5 ± 1.8 25.5 ± 0.8 27.2 ± 1.4 25.3 ± 1.1 25.6 ± 0.7 25.08 ± 1.3
Final body weight (g) 29.3 ± 1.7 28.8 ± 1.3 29.7 ± 1.5 27.7 ± 0.4 28.3 ± 1.2 27.1 ± 0.8
Gain 10.8% 13.1% 9.1% 9.3% 10.5% 7.9%
TA weight (mg) 57.9 ± 4.8 54.7 ± 4.3 54.2 ± 4.9 56 ± 3.7 50.4 ± 4.9* 45.9 ± 3.7*+
TA CSA (μm2) 1529 ± 130 1595 ± 266 1585 ± 264 1428 ± 222 1377 ± 140 1386 ± 60
Data are reported as means ± SD for 5 mice per group. TA = tibialis anterior muscle; CSA = cross-sectional area; Control = non-
trained and non-sensitized group; OA = ovalbumin-sensitized group; PT50% = group submitted to treadmill training at 50% maximum
speed and non-sensitized; PT75% = group submitted to treadmill training at 75% maximum speed and non-sensitized; OA+PT50% =
OA-sensitized group submitted to treadmill training at 50% maximum speed; OA+PT75% = OA-sensitized group submitted to
treadmill training at 75% maximum speed. *P < 0.05 compared to control; +P < 0.05 compared to OA, PT50% and PT75% (ANOVA
and Tukey test).
Figure 1. Effect of training on maximal exercise capacity. Data
are reported as means ± SD of the difference between the first
and second tests in minutes for 5 mice in each group. Normal
tibialis anterior muscle (control); OA = ovalbumin-sensitized
group; PT50% = group submitted to physical training at 50%
maximum speed and non-sensitized; PT75% = group submitted
to treadmill training at 75% maximum speed and non-sensitized;
OA+PT50% = OA-sensitized group submitted to treadmill train-
ing at 50% maximum speed; OA+PT75% = OA-sensitized group
submitted to treadmill training at 75% maximum speed. *P < 0.05
compared with non-trained groups (control and OA; ANOVA and
Tukey test).
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Discussion
To our knowledge, this is the first study of the effects of
prolonged treadmill training of different intensities on the
expression of gene markers of muscle atrophy in peripher-
al skeletal muscle in an atopic asthma mouse model. Lung
inflammation did not modify muscle fiber CSA or atrogin-1
and MuRF1 gene expression in the TA muscle. However,
treadmill training reduced the expression of these genes in
all exercised groups, a fact that could be beneficial in
cachexia and disuse conditions.
Recent studies have shown an increase of molecular
markers of muscle atrophy in human COPD (8,9). Doucet
and colleagues (8) reported an increase in the activation of
muscle atrophy by the up-regulation of atrogin-1 and MuRF1
in the quadriceps muscle of COPD patients. They provided
relevant information about a potential molecular mechan-
ism underlying the development of quadriceps muscle
atrophy and weakness in these patients, since atrogin-1
and MuRF1 have been found to be markedly up-regulated
during cachexia- and disuse-induced atrophy (10-12).
Interestingly, the present results demonstrated that a
short period of OA was not effective in inducing muscle
atrophy or in modifying the molecular markers for muscle
atrophy in mouse TA muscles. These results are interest-
ing when compared with those of Doucet and colleagues
(8). Probably, the differences between the present study
and the report of Doucet et al. (8) could be related to the
different lung diseases and models assessed, since in the
present study an asthmatic mouse model was studied,
whereas Doucet et al. (8) evaluated COPD disease in
humans. The absence of molecular markers for muscle
atrophy in the present OA group could be attributed to the
short period (4 weeks) of the allergic sensitization protocol,
which may not have been long enough to induce skeletal
muscle atrophy. Furthermore, although it is difficult to
undertake such a study in humans for ethical reasons,
future investigations will be necessary for comparative
purposes.
Additionally, in the present study the TA muscle was
assessed, which is composed of a high percentage of fast-
twitch fibers. It should be interesting to examine skeletal
muscle with a high percentage of slow-twitch fibers, which
are more susceptible to disuse atrophy than fast-twitch
fibers (30).
It has been generally accepted that the mouse model of
atopic asthma following OA is similar to asthmatic reaction
in humans with regards to airway inflammation (31). Nev-
ertheless, there is little information about whether this
model triggers the mechanism of peripheral skeletal muscle
weakness and atrophy, as observed in asthmatic subjects.
The results of the present study suggest that only 4 weeks
of atopic asthma following OA was not long enough to
induce muscle fiber atrophy in the mouse.
In spite of the well-described effects of aerobic training
of moderate intensity in eliciting anti-inflammatory effects
in asthma (21,24), no information is available regarding the
effects of training on peripheral skeletal muscle in this
disease. Previous studies have demonstrated that this
type of exercise may be used to prevent muscle atrophy
under disuse conditions (32,33). The present study showed
that treadmill physical training did not alter the CSA of the
TA muscle fibers, which is consistent with a study that
reported that 12 weeks of treadmill physical training (75%
of VO2max) had no effect on the CSA of the TA muscle in
young rats (33).
Figure 2. Effect of exercise training on the atrogin-1 (A) and
MuRF1 (B) mRNA levels in mouse tibialis anterior muscle. Data
are reported as means ± SD for 5 mice in each group. Normal
tibialis anterior muscle (control); OA = ovalbumin-sensitized
group; PT50% = group submitted to physical training at 50%
maximum speed and non-sensitized; PT75% = group submitted
to treadmill training at 75% maximum speed and non-sensitized;
OA+PT50% = OA-sensitized group submitted to treadmill train-
ing at 50% maximum speed; OA+PT75% = OA-sensitized group
submitted to treadmill training at 75% maximum speed. *P < 0.05
for the PT50%, OA+PT50%, PT75%, and OA+PT75% groups
compared to the control group (ANOVA and Tukey test).
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Although the present study did not detect a change in
the CSA of the TA muscle fibers after aerobic treadmill
training, other studies have demonstrated that aerobic
training improves respiratory and peripheral muscle strength
and function (19,20), aspects that were not evaluated
here.
It is interesting to note that both types of physical
training (50 and 75%) reduced the accumulation of atrogin-
1 and MuRF1 mRNA in TA muscle in both asthmatic and
non-asthmatic groups compared to non-trained groups.
Reduction of atrogin-1 and MuRF1 mRNA levels by aero-
bic exercise may provide protection against myoprotein
degradation and reduced contractile function inherent to
muscle cachexia and disuse. Clinically, these findings
should be important in physical rehabilitation, since this
protocol was sufficient to change the expression of muscle-
specific genes related to the atrophy pathway. Neverthe-
less, studies in humans are also necessary to examine this
hypothesis.
Additionally, the evaluation of other muscles, both pe-
ripheral (quadriceps and soleus) and respiratory (dia-
phragm) could be useful for a better understanding of the
extent of muscular benefits of aerobic training for asth-
matic patients. Aerobic training of low and moderate inten-
sity has been proposed to increase the antioxidant proper-
ties and decrease the production of oxidants, resulting in a
decrease of muscle damage and in an optimal generation
of isometric force (34,35). In spite of the maintenance of
muscle fiber CSA observed in the present trained groups,
the reduction of reactive oxygen species production inher-
ent to aerobic training (34,35) could justify the decrease of
atrogin-1 and MuRF1 expression in trained and non-trained
groups, since recent evidence implicates oxidative stress
as a key regulator of atrophy cell signaling pathways (36).
Acknowledgments
The authors are grateful to Tereza F. Piassi, from
Federal University of São Carlos, São Carlos, SP, Brazil,
for technical assistance.
References
1. U.S. National Institutes of Health. Global Initiate for Asthma
(GINA), from workshop report of global strategy for asthma
management and prevention issued 1995 and revised 2006.
Washington: Government Printing Office; 2006.
2. Kuhn C III, Homer RJ, Zhu Z, Ward N, Flavell RA, Geba GP,
et al. Airway hyperresponsiveness and airway obstruction
in transgenic mice. Morphologic correlates in mice overex-
pressing interleukin (IL)-11 and IL-6 in the lung. Am J Respir
Cell Mol Biol 2000; 22: 289-295.
3. Matsumoto H, Niimi A, Takemura M, Ueda T, Minakuchi M,
Tabuena R, et al. Relationship of airway wall thickening to
an imbalance between matrix metalloproteinase-9 and its
inhibitor in asthma. Thorax 2005; 60: 277-281.
4. Clark CJ, Cochrane LM. Assessment of work performance
in asthma for determination of cardiorespiratory fitness and
training capacity. Thorax 1988; 43: 745-749.
5. Goldney RD, Ruffin R, Fisher LJ, Wilson DH. Asthma symp-
toms associated with depression and lower quality of life: a
population survey. Med J Aust 2003; 178: 437-441.
6. Mancuso CA, Sayles W, Robbins L, Phillips EG, Ravenell K,
Duffy C, et al. Barriers and facilitators to healthy physical
activity in asthma patients. J Asthma 2006; 43: 137-143.
7. Lucas SR, Platts-Mills TA. Physical activity and exercise in
asthma: relevance to etiology and treatment. J Allergy Clin
Immunol 2005; 115: 928-934.
8. Doucet M, Russell AP, Leger B, Debigare R, Joanisse DR,
Caron MA, et al. Muscle atrophy and hypertrophy signaling
in patients with chronic obstructive pulmonary disease. Am
J Respir Crit Care Med 2007; 176: 261-269.
9. Ottenheijm CA, Heunks LM, Li YP, Jin B, Minnaard R, van
Hees HW, et al. Activation of the ubiquitin-proteasome path-
way in the diaphragm in chronic obstructive pulmonary dis-
ease. Am J Respir Crit Care Med 2006; 174: 997-1002.
10. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V,
Bailey J, et al. Multiple types of skeletal muscle atrophy
involve a common program of changes in gene expression.
FASEB J 2004; 18: 39-51.
11. Lecker SH, Solomon V, Mitch WE, Goldberg AL. Muscle
protein breakdown and the critical role of the ubiquitin-
proteasome pathway in normal and disease states. J Nutr
1999; 129: 227S-237S.
12. McKinnell IW, Rudnicki MA. Molecular mechanisms of
muscle atrophy. Cell 2004; 119: 907-910.
13. American Association of Cardiovascular and Pulmonary
Rehabilitation. Guidelines of pulmonary rehabilitation pro-
grams. 2nd edn. Champaign: Human Kinetics; 1998.
14. British Thoracic Society Standards of Care Subcommittee
on Pulmonary Rehabilitation. Pulmonary rehabilitation. Tho-
rax 2001; 56: 827-834.
15. Carroll N, Sly P. Exercise training as an adjunct to asthma
management? Thorax 1999; 54: 190-191.
16. Fanelli A, Cabral AL, Neder JA, Martins MA, Carvalho CR.
Exercise training on disease control and quality of life in
asthmatic children. Med Sci Sports Exerc 2007; 39: 1474-
1480.
17. Neder JA, Nery LE, Silva AC, Cabral AL, Fernandes AL.
Short-term effects of aerobic training in the clinical manage-
ment of moderate to severe asthma in children. Thorax
1999; 54: 202-206.
18. Ram FS, Robinson SM, Black PN, Picot J. Physical training
345
Braz J Med Biol Res 42(4) 2009
Muscle gene expression in asthma
www.bjournal.com.br
for asthma. Cochrane Database Syst Rev 2005; CD001116.
19. Counil FP, Varray A, Matecki S, Beurey A, Marchal P,
Voisin M, et al. Training of aerobic and anaerobic fitness in
children with asthma. J Pediatr 2003; 142: 179-184.
20. Counil FP, Voisin M. Physical fitness in children with asthma.
Arch Pediatr 2006; 13: 1136-1141.
21. Vieira RP, Claudino RC, Duarte AC, Santos AB, Perini A,
Faria Neto HC, et al. Aerobic exercise decreases chronic
allergic lung inflammation and airway remodeling in mice.
Am J Respir Crit Care Med 2007; 176: 871-877.
22. Dimitrijevic MM, Dimitrijevic MR. Clinical elements for the
neuromuscular stimulation and functional electrical stimula-
tion protocols in the practice of neurorehabilitation. Artif
Organs 2002; 26: 256-259.
23. McComas AJ. Human neuromuscular adaptations that ac-
company changes in activity. Med Sci Sports Exerc 1994;
26: 1498-1509.
24. Pastva A, Estell K, Schoeb TR, Atkinson TP, Schwiebert
LM. Aerobic exercise attenuates airway inflammatory re-
sponses in a mouse model of atopic asthma. J Immunol
2004; 172: 4520-4526.
25. Ram FS, Robinson SM, Black PN. Effects of physical train-
ing in asthma: a systematic review. Br J Sports Med 2000;
34: 162-167.
26. National Research Council. Guide for the care and use of
laboratory animals. Washington: National Academy Press;
1996.
27. Peviani SM, Gomes AR, Moreira RF, Moriscot AS, Salvini
TF. Short bouts of stretching increase myo-D, myostatin
and atrogin-1 in rat soleus muscle. Muscle Nerve 2007; 35:
363-370.
28. Russo TL, Peviani SM, Freria CM, Gigo-Benato D, Geuna
S, Salvini TF. Electrical stimulation based on chronaxie
reduces atrogin-1 and myoD gene expressions in dener-
vated rat muscle. Muscle Nerve 2007; 35: 87-97.
29. Luden N, Jemiolo B, Whitsett D, Trappe S. Effects of 13
weeks of aerobic training on basal gene expression. FASEB
J 2007; 21: 921-929.
30. Lieber RL. Skeletal muscle structure, function, and plastic-
ity, the physiological basis of rehabilitation. Philadelphia:
Lippincott; 2002.
31. Tang LF, Du LZ, Zou CC, Gu WZ. Levels of matrix metallo-
proteinase-9 and its inhibitor in guinea pig asthma model
following ovalbumin challenge. Fetal Pediatr Pathol 2005;
24: 81-87.
32. Diaz-Herrera P, Torres A, Morcuende JA, Garcia-Castellano
JM, Calbet JA, Sarrat R. Effect of endurance running on
cardiac and skeletal muscle in rats. Histol Histopathol 2001;
16: 29-35.
33. Song W, Kwak HB, Lawler JM. Exercise training attenuates
age-induced changes in apoptotic signaling in rat skeletal
muscle. Antioxid Redox Signal 2006; 8: 517-528.
34. Faucher M, Steinberg JG, Barbier D, Hug F, Jammes Y.
Influence of chronic hypoxemia on peripheral muscle func-
tion and oxidative stress in humans. Clin Physiol Funct
Imaging 2004; 24: 75-84.
35. Reid MB. Invited Review: redox modulation of skeletal
muscle contraction: what we know and what we don’t. J
Appl Physiol 2001; 90: 724-731.
36. Powers SK, Kavazis AN, McClung JM. Oxidative stress and
disuse muscle atrophy. J Appl Physiol 2007; 102: 2389-
2397.
